EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus

Susannah von Hofsten iD, Kristin Andreassen Fenton iD, Hege Lynum Pedersen iD

International Journal of Molecular Sciences · 14.05.2024 · 25 (10) · 5351

DOI: 10.3390/ijms25105351 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2024. Verfasst von Susannah von Hofsten und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, 9019 Tromsø, Norway. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Toll-Like Receptor 7. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Norway Regional Health Authority, UiT The Arctic University of Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pathogenesis of systemic lupus erythematosus (SLE) is linked to the differential roles of toll-like receptors (TLRs), particularly TLR7, TLR8, and TLR9. TLR7 overexpression or gene duplication, as seen with the Y-linked autoimmune accelerator (Yaa) locus or TLR7 agonist imiquimod, correlates with increased SLE severity, and specific TLR7 polymorphisms and gain-of-function variants are associated with enhanced SLE susceptibility and severity. In addition, the X-chromosome location of TLR7 and its escape from X-chromosome inactivation provide a genetic basis for female predominance in SLE. The absence of TLR8 and TLR9 have been shown to exacerbate the detrimental effects of TLR7, leading to upregulated TLR7 activity and increased disease severity in mouse models of SLE. The regulatory functions of TLR8 and TLR9 have been proposed to involve competition for the endosomal trafficking chaperone UNC93B1. However, recent evidence implies more direct, regulatory functions of TLR9 on TLR7 activity. The association between age-associated B cells (ABCs) and autoantibody production positions these cells as potential targets for treatment in SLE, but the lack of specific markers necessitates further research for precise therapeutic intervention. Therapeutically, targeting TLRs is a promising strategy for SLE treatment, with drugs like hydroxychloroquine already in clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicToll-Like Receptor 7AnimalsHumansMiceToll-Like ReceptorsToll-Like Receptor 8Disease Models, AnimalGenetic Predisposition to Disease

Stichwörter der Autor:innen

mouse modelssystemic lupus erythematosustoll-like receptor

Substanzen

Toll-Like Receptor 7Toll-Like ReceptorsToll-Like Receptor 8TLR7 protein, human

Autor:innen und Institutionen

  • Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, 9019 Tromsø, Norway.
  • Centre of Clinical Research and Education, University Hospital of North Norway, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, 9019 Tromsø, Norway.

ORCID-Profile: Susannah von Hofsten, Kristin Andreassen Fenton, Hege Lynum Pedersen

Förderung

  • Northern Norway Regional Health Authority
  • UiT The Arctic University of Norway

Zitieren

APA

von Hofsten, S., Fenton, K. A., & Pedersen, H. L. (2024). Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 25(10), 5351. https://doi.org/10.3390/ijms25105351

Vancouver

von Hofsten S, Fenton KA, Pedersen HL. Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2024;25(10):5351. doi:10.3390/ijms25105351

BibTeX
@article{vonHofsten2024,
  author = {von Hofsten, Susannah and Fenton, Kristin Andreassen and Pedersen, Hege Lynum},
  title = {Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5351},
  doi = {10.3390/ijms25105351}
}
Kostenlos starten →